Skip to content

Babies' outcome of mothers with overt Hyper-/Hypo-thyroidism

Babies' outcome of mothers with overt Hyper-/Hypo-thyroidism - BOMOH2T

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000019819
Enrollment
290
Registered
2015-11-19
Start date
2015-11-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Grave&#39

Interventions

None listed

Sponsors

National Center for Child Health and Development, Tokyo, Japan
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Pregnant women with Graves' disease (untreated, oral medicine, post radioactive iodine therapy, post operation, remission), Pregnant women with autonomously functioning thyroid nodules, Pregnant women with hypothyroidism by TSH-receptor blocking antibodies

Exclusion criteria

Exclusion criteria: 1)planning to delivery at other institutions 2)primary outcome'Neuropsychological development'only: born from mothers with Graves' diasese keeping remission, multiple malformation, chromosomal abnormality, born before 34 completed weeks of gestation

Design outcomes

Primary

MeasureTime frame
Preterm, Low birth weight or macrosomia, Fetal thyroid dysfunction, Neonatal thyroid dysfunction, Neuropsychological development at 1,3,6 years of age

Countries

Japan

Contacts

Public ContactShiori Sato

National Center for Child Health and Development, Tokyo, Japan Maternal Medicine

boseinaika@ncchd.go.jp03-3416-0181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026